---
title: "Luoxin Pharmaceutical: Net profit in the first half of 2025 was 17.695 million yuan, a year-on-year increase of 119.95%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/254800775.md"
description: "Luoxin Pharmaceutical announced that its operating revenue in the first half of 2025 was 1.077 billion yuan, a year-on-year decrease of 14.45%. Net profit was 17.695 million yuan, a year-on-year increase of 119.95%"
datetime: "2025-08-27T11:39:26.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/254800775.md)
  - [en](https://longbridge.com/en/news/254800775.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/254800775.md)
generator: "portal-rs"
---

# Luoxin Pharmaceutical: Net profit in the first half of 2025 was 17.695 million yuan, a year-on-year increase of 119.95%

Luoxin Pharmaceutical announced that its operating revenue in the first half of 2025 was 1.077 billion yuan, a year-on-year decrease of 14.45%. The net profit was 17.695 million yuan, a year-on-year increase of 119.95%

### Related Stocks

- [002793.CN](https://longbridge.com/en/quote/002793.CN.md)

## Related News & Research

- [Livzon Pharma buys 3.5% Xinbeijiang Pharma stake for RMB 106.7 million](https://longbridge.com/en/news/296601614.md)
- [FOCUS-Green giant: How Taylor Farms became a top salad supplier before US diarrhea outbreak](https://longbridge.com/en/news/296469939.md)
- [Vector Science files US provisional patent for orthopedic tissue-regeneration peptide platform](https://longbridge.com/en/news/296483037.md)
- [Alpha Entrepreneurial Partners Investment TGV takes 3.03% stake in q.beyond voting rights](https://longbridge.com/en/news/296450706.md)
- [Lighthouse Canton favors EM high-yield sovereigns as developed-market fiscal risks rise](https://longbridge.com/en/news/296183818.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**